NDC 0480-3275 Alvaiz
Eltrombopag Tablet, Film Coated Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Product Characteristics
WHITE (C48325 - OFF-WHITE)
RED (C48326)
8 MM
10 MM
TV;Z18
TV;Z36
Code Structure Chart
Product Details
What is NDC 0480-3275?
What are the uses for Alvaiz?
What are Alvaiz Active Ingredients?
Which are Alvaiz UNII Codes?
The UNII codes for the active ingredients in this product are:
- ELTROMBOPAG CHOLINE (UNII: F9G8XE24IB)
- ELTROMBOPAG (UNII: S56D65XJ9G) (Active Moiety)
Which are Alvaiz Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- COPOVIDONE K25-31 (UNII: D9C330MD8B)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLOXAMER 188 (UNII: LQA7B6G8JG)
- POLYETHYLENE GLYCOL 4000 (UNII: 4R4HFI6D95)
- POVIDONE K12 (UNII: 333AG72FWJ)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- FD&C BLUE NO. 1 ALUMINUM LAKE (UNII: J9EQA3S2JM)
- POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)
- POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- HYPROMELLOSE 2910 (3 MPA.S) (UNII: 0VUT3PMY82)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for Alvaiz?
- RxCUI: 2675187 - eltrombopag 18 MG Oral Tablet
- RxCUI: 2675187 - eltrombopag 18 MG (as eltrombopag choline 22.2 MG) Oral Tablet
- RxCUI: 2675193 - Alvaiz 18 MG Oral Tablet
- RxCUI: 2675193 - eltrombopag 18 MG Oral Tablet [Alvaiz]
- RxCUI: 2675193 - Alvaiz 18 MG (as eltrombopag choline 22.2 MG) Oral Tablet
Which are the Pharmacologic Classes for Alvaiz?
- Breast Cancer Resistance Protein Inhibitors - [MoA] (Mechanism of Action)
- Increased Megakaryocyte Maturation - [PE] (Physiologic Effect)
- Increased Platelet Production - [PE] (Physiologic Effect)
- Organic Anion Transporting Polypeptide 1B1 Inhibitors - [MoA] (Mechanism of Action)
- Thrombopoietin Receptor Agonist - [EPC] (Established Pharmacologic Class)
- Thrombopoietin Receptor Agonists - [MoA] (Mechanism of Action)
- UGT1A1 Inhibitors - [MoA] (Mechanism of Action)
- UGT1A3 Inhibitors - [MoA] (Mechanism of Action)
- UGT1A4 Inhibitors - [MoA] (Mechanism of Action)
- UGT1A6 Inhibitors - [MoA] (Mechanism of Action)
- UGT1A9 Inhibitors - [MoA] (Mechanism of Action)
- UGT2B15 Inhibitors - [MoA] (Mechanism of Action)
- UGT2B7 Inhibitors - [MoA] (Mechanism of Action)
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".